Mwelwa Chibuye

ORCID, self-asserted

ORCID 0000-0002-7609-9698

Publications

Citations

178

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

15 works in the graph, newest first.

Distinct infant resistome trajectories shaped by country income and geography revealed through global metagenomics reanalysis
2026npj Antimicrobials and ResistanceJournalOpen access1 citations10.1038/s44259-026-00194-8
Statistical Modelling of Waning Immunity After Shanchol™ Vaccination: A Prospective Cohort Study
2026VaccinesJournalOpen access0 citations10.3390/vaccines14020147
Pre-vaccination biomarkers of enteric dysfunction, inflammation and nutritional status associate with seroconversion to oral cholera vaccine and are perturbed during natural infection
2026Frontiers in ImmunologyJournalOpen access0 citations10.3389/fimmu.2026.1917668
Genomic analysis and antimicrobial resistance of Vibrio cholerae isolated during Zambia’s 2023 cholera epidemic
2025Microbial GenomicsJournalOpen access3 citations10.1099/mgen.0.001566
Systematic review of associations between gut microbiome composition and stunting in under-five children
2024npj Biofilms and MicrobiomesJournalOpen accessFirst author37 citations10.1038/s41522-024-00517-5
The Incidence and Risk Factors for Enterotoxigenic E. coli Diarrheal Disease in Children under Three Years Old in Lusaka, Zambia
2024MicroorganismsJournalOpen access7 citations10.3390/microorganisms12040698
Comparative analysis of cholera serum vibriocidal antibodies from Convalescent and vaccinated adults in Zambia
2024VaccineJournal2 citations10.1016/j.vaccine.2024.05.027
Impact of antibiotics on gut microbiome composition and resistome in the first years of life in low- to middle-income countries: A systematic review
2023PLoS MedicineJournalOpen accessCorresponding64 citations10.1371/journal.pmed.1004235
Safety, tolerability, and immunogenicity of an oral inactivated ETEC vaccine (ETVAX®) with dmLT adjuvant in healthy adults and children in Zambia: An age descending randomised, placebo-controlled trial
2023VaccineJournalOpen access17 citations10.1016/j.vaccine.2023.09.052
Prevalence of Diarrhoeagenic Escherichia coli among Children Aged between 0–36 Months in Peri-Urban Areas of Lusaka
2023MicroorganismsJournalOpen access13 citations10.3390/microorganisms11112790
Evaluation of ROTARIX® Booster Dose Vaccination at 9 Months for Safety and Enhanced Anti-Rotavirus Immunity in Zambian Children: A Randomised Controlled Trial
2023VaccinesJournalOpen access10 citations10.3390/vaccines11020346
Association of biomarkers of enteric dysfunction, systemic inflammation, and growth hormone resistance with seroconversion to oral rotavirus vaccine: A lasso for inference approach
2023PLoS ONEJournalOpen access3 citations10.1371/journal.pone.0293101
Sensitivity and predictive value of dysentery in diagnosing shigellosis among under five children in Zambia
2023PLoS ONEJournalOpen access8 citations10.1371/journal.pone.0279012
Maternal and Infant Histo-Blood Group Antigen (HBGA) Profiles and Their Influence on Oral Rotavirus Vaccine (RotarixTM) Immunogenicity among Infants in Zambia
2023VaccinesJournalOpen access1 citations10.3390/vaccines11081303
Development of a diarrhoea severity scoring scale in a passive health facility-based surveillance system
2022PLoS ONEJournalOpen access12 citations10.1371/journal.pone.0272981